Afala - a drug used to treat diseases of the prostate gland.
Release form and composition
Afal's tablets are made for sucking. 1 tablet contains antibodies to a prostate-specific antigen affinity purified in the amount of 3 mg.
Auxiliary components of the medicine are magnesium stearate, microcrystalline cellulose, lactose.
In blister packs of 20 tablets.
Indications for use
According to the instructions, Afala is prescribed to patients with:
- Benign prostatic hyperplasia stage 1 and 2;
- Dysuric disorders (frequent night and day urge to urinate, discomfort and pain in the perineum, difficulty urinating), which usually accompany acute and chronic prostatitis, benign prostatic hyperplasia of the 1 st and 2 nd stages.
As part of the complex treatment, Afal is prescribed for the treatment of chronic and acute prostatitis as an anesthetic and anti-inflammatory agent.
According to the instructions Afala is contraindicated in:
- Hypersensitivity to the active or auxiliary components of the drug;
- Galactosemia, lactase deficiency, glucose-galactose malabsorption syndrome.
The drug Afala is not intended for use in pediatric practice.
Dosing and Administration
Afala is applied sublingually. Prescribe the drug in a dose of 2 tablets per dose twice a day (morning and evening). The tablets are kept in the mouth until completely dissolved.
To achieve optimal therapeutic action for half an hour before the application of Afal and within 30 minutes after you should not eat and drink fluids.
The duration of therapy is determined by the attending physician, depending on the clinical picture and the particular course of the disease in the patient. On average, the duration of treatment is 16 weeks.
In dysuric disorders, accompanied by severe pain, it is allowed to take the drug in the amount of 2 tablets four times a day during the first 2-3 weeks of treatment, after which the dose is reduced to 2 tablets twice a day.
According to the doctor's recommendation, a second course of treatment is possible in 1-4 months.
In case of overdose, the patient may experience dyspeptic symptoms caused by additional substances that are part of Afal.
As a rule, the use of Afal by patients is well tolerated.
The most common side effects are:
- Digestive disorders.
These symptoms do not require discontinuation of the drug and after a while pass on their own. If they bring the patient inconvenience, it is recommended to consult your doctor to adjust the dose of the medicine.
The combination of Afala with drugs intended for the treatment of prostatitis and benign prostatic hyperplasia is allowed.
To date, incidents of Afal's incompatibility with any drugs have not been found.
Afala has no analogues on the active substance. Analogues of the drug, having a similar therapeutic effect, are:
Terms and conditions of storage
The drug Afala is recommended to be stored for no longer than 3 years in rooms with a temperature not exceeding 25 degrees Celsius.